Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Mar;59(3):949–954. doi: 10.1128/iai.59.3.949-954.1991

Modifications of plasma fibronectin in cystic fibrosis patients.

L Stanislawski 1, M Sorin 1
PMCID: PMC258351  PMID: 1997440

Abstract

Recurrent pulmonary infections with Staphylococcus aureus and Pseudomonas aeruginosa are a major problem in cystic fibrosis (CF), leading to severe and progressive deterioration of the respiratory tract. Fibronectin (FN) has a binding site(s) for S. aureus and Streptococcus pyogenes. This bacterial bindings site(s) was studied by using FN from patients with CF and comparing them with FN purified from the plasma of bronchitis and normal subjects by an enzyme-linked immunosorbent assay technique. We found a decreased binding of the CF FN to these bacteria in all seven CF patients. Other differences between the CF FN and normal FN were a marked modification in the pattern of peptide migration in polyacrylamide gel electrophoresis after hydrolysis with various proteinases and an increase or decrease of the total sugar content of the FN.

Full text

PDF
949

Images in this article

951Image
on p.951
952Image
on p.952
952Image
on p.952
953Image
on p.953

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham S. N., Beachey E. H., Simpson W. A. Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun. 1983 Sep;41(3):1261–1268. doi: 10.1128/iai.41.3.1261-1268.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ben-Yoseph Y., Defranco C. L., Nadler H. L. Decreased sialic acid and altered binding to lectins of purified alpha 2-macroglobulin from patients with cystic fibrosis. Clin Chim Acta. 1979 Nov 15;99(1):31–35. doi: 10.1016/0009-8981(79)90136-0. [DOI] [PubMed] [Google Scholar]
  3. Bernard B. A., Yamada K. M., Olden K. Carbohydrates selectively protect a specific domain of fibronectin against proteases. J Biol Chem. 1982 Jul 25;257(14):8549–8554. [PubMed] [Google Scholar]
  4. Courtney H. S., Simpson W. A., Beachey E. H. Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol. 1983 Feb;153(2):763–770. doi: 10.1128/jb.153.2.763-770.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Czop J. K., McGowan S. E., Center D. M. Opsonin-independent phagocytosis by human alveolar macrophages: augmentation by human plasma fibronectin. Am Rev Respir Dis. 1982 May;125(5):607–609. doi: 10.1164/arrd.1982.125.5.607. [DOI] [PubMed] [Google Scholar]
  6. DISCHE Z., DI SANT'AGNESE P., PALLAVICINI C., YOULOS J. Composition of mucoprotein fractions from duodenal fluid of patients with cystic fibrosis of the pancreas and from controls. Pediatrics. 1959 Jul;24(1):74–91. [PubMed] [Google Scholar]
  7. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  8. Gershoni J. M., Bayer E. A., Wilchek M. Blot analyses of glycoconjugates: enzyme-hydrazide--a novel reagent for the detection of aldehydes. Anal Biochem. 1985 Apr;146(1):59–63. doi: 10.1016/0003-2697(85)90395-1. [DOI] [PubMed] [Google Scholar]
  9. Hermelin B., Bertrand F., Blivet M. J., Picard J. Change in activities of lysosomal glycosidases in skin fibroblasts from controls and patients with cystic fibrosis. Cell Mol Biol. 1987;33(1):83–89. [PubMed] [Google Scholar]
  10. Kluftinger J. L., Kelly N. M., Jost B. H., Hancock R. E. Fibronectin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages. Infect Immun. 1989 Sep;57(9):2782–2785. doi: 10.1128/iai.57.9.2782-2785.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kornblihtt A. R., Umezawa K., Vibe-Pedersen K., Baralle F. E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 1985 Jul;4(7):1755–1759. doi: 10.1002/j.1460-2075.1985.tb03847.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature. 1978 Dec 14;276(5689):718–720. doi: 10.1038/276718a0. [DOI] [PubMed] [Google Scholar]
  13. Morrissey J. H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem. 1981 Nov 1;117(2):307–310. doi: 10.1016/0003-2697(81)90783-1. [DOI] [PubMed] [Google Scholar]
  14. Mosher D. F., Proctor R. A. Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science. 1980 Aug 22;209(4459):927–929. doi: 10.1126/science.7403857. [DOI] [PubMed] [Google Scholar]
  15. Olden K., Pratt R. M., Yamada K. M. Role of carbohydrate in biological function of the adhesive glycoprotein fibronectin. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3343–3347. doi: 10.1073/pnas.76.7.3343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Oyama F., Hirohashi S., Shimosato Y., Titani K., Sekiguchi K. Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors. J Biol Chem. 1989 Jun 25;264(18):10331–10334. [PubMed] [Google Scholar]
  17. Pearson R. D., Lubin A. H. Increased heparin binding in cystic fibrosis: a reflection of altered glycoprotein biosynthesis? Pediatr Res. 1979 Jul;13(7):834–840. doi: 10.1203/00006450-197907000-00008. [DOI] [PubMed] [Google Scholar]
  18. Ruoslahti E., Engvall E. Immunochemical and collagen-binding properties of fibronectin. Ann N Y Acad Sci. 1978 Jun 20;312:178–191. doi: 10.1111/j.1749-6632.1978.tb16802.x. [DOI] [PubMed] [Google Scholar]
  19. Rydén C., Rubin K., Speziale P., Hök M., Lindberg M., Wadström T. Fibronectin receptors from Staphylococcus aureus. J Biol Chem. 1983 Mar 10;258(5):3396–3401. [PubMed] [Google Scholar]
  20. Sekiguchi K., Hakomori S. Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins. J Biol Chem. 1983 Mar 25;258(6):3967–3973. [PubMed] [Google Scholar]
  21. Stanislawski L., Courtney H. S., Simpson W. A., Hasty D. L., Beachey E. H., Robert L., Ofek I. Hybridoma antibodies to the lipid-binding site(s) in the amino-terminal region of fibronectin inhibits binding of streptococcal lipoteichoic acid. J Infect Dis. 1987 Aug;156(2):344–349. doi: 10.1093/infdis/156.2.344. [DOI] [PubMed] [Google Scholar]
  22. Stanislawski L., Simpson W. A., Hasty D., Sharon N., Beachey E. H., Ofek I. Role of fibronectin in attachment of Streptococcus pyogenes and Escherichia coli to human cell lines and isolated oral epithelial cells. Infect Immun. 1985 Apr;48(1):257–259. doi: 10.1128/iai.48.1.257-259.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Van de Water L., Destree A. T., Hynes R. O. Fibronectin binds to some bacteria but does not promote their uptake by phagocytic cells. Science. 1983 Apr 8;220(4593):201–204. doi: 10.1126/science.6338594. [DOI] [PubMed] [Google Scholar]
  25. Vercellotti G. M., Lussenhop D., Peterson P. K., Furcht L. T., McCarthy J. B., Jacob H. S., Moldow C. F. Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med. 1984 Jan;103(1):34–43. [PubMed] [Google Scholar]
  26. Wilson G. B., Fudenberg H. H. Studies on cystic fibrosis using isoelectric focusing. II. Demonstration of deficient proteolytic cleavage of alpha2-macroglobulin in cystic fibrosis plasma. Pediatr Res. 1976 Feb;10(2):87–96. doi: 10.1203/00006450-197602000-00003. [DOI] [PubMed] [Google Scholar]
  27. Woods D. E., Straus D. C., Johanson W. G., Jr, Bass J. A. Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest. 1981 Dec;68(6):1435–1440. doi: 10.1172/JCI110395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yamada K. M. Cell surface interactions with extracellular materials. Annu Rev Biochem. 1983;52:761–799. doi: 10.1146/annurev.bi.52.070183.003553. [DOI] [PubMed] [Google Scholar]
  29. Zhu B. C., Fisher S. F., Pande H., Calaycay J., Shively J. E., Laine R. A. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin. J Biol Chem. 1984 Mar 25;259(6):3962–3970. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES